Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sarepta Therapeutics Inc Announces Proposed Public Offering Of Common Stock


Wednesday, 12 Dec 2012 04:01pm EST 

Sarepta Therapeutics Inc announced that it is offering to sell, shares of its common stock in an underwritten public offering. Sarepta also intends to grant the underwriters a 30-day option to purchase from it up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if any. Lazard Capital Markets LLC is acting as the sole book-running manager of the offering. Sarepta intends to use the net proceeds from the offering for general corporate purposes, including the continued development of eteplirsen and other product candidates. 

Company Quote

21.21
-0.13 -0.61%
10:48am EDT